Expedited approval programs at the Food and Drug Administration

被引：1
|
作者：
Begg, Colin B. [1 ]
Ellenberg, Susan S. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 2nd Floor,485 Lexington Ave, New York, NY 10017 USA
[2] Univ Penn, CCEB, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
CLINICAL TRIALS | 2018年 / 15卷 / 03期
关键词：
D O I：
10.1177/1740774518770653
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [1] Expedited programs for drug development and approval
    Pariser, Anne R.
    Robb, Melissa
    Sherman, Rachel E.
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (07): : 507 - 510
  • [2] Expedited Development Programs at the Food and Drug Administration: Insights and Opportunities
    Collins, Grace
    Stewart, Mark
    Sigal, Ellen
    Allen, Jeff
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (03) : 619 - 621
  • [3] Expedited Development Programs at the Food and Drug Administration: Insights and Opportunities
    Grace Collins
    Mark Stewart
    Ellen Sigal
    Jeff Allen
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 619 - 621
  • [4] The US Food and Drug Administration's expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation
    Wallach, Joshua D.
    Ross, Joseph S.
    Naci, Huseyin
    CLINICAL TRIALS, 2018, 15 (03) : 243 - 246
  • [5] The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements
    Wallach, Joshua D.
    Ross, Joseph S.
    Naci, Huseyin
    CLINICAL TRIALS, 2018, 15 (03) : 219 - 229
  • [6] IMPACT OF FDA EXPEDITED REVIEW PROGRAMS ON NEW DRUG APPROVAL TIME
    Ronnebaum, S.
    Smith, D.
    Andrawes, M.
    VALUE IN HEALTH, 2024, 27 (06) : S7 - S7
  • [7] Food and drug administration approval status
    Jöechle, W
    JOURNAL OF EQUINE VETERINARY SCIENCE, 2004, 24 (09) : 366 - 366
  • [8] THE FOOD-AND-DRUG-ADMINISTRATION DRUG APPROVAL PROCESS
    AHART, GJ
    CONNECTICUT MEDICINE, 1980, 44 (03) : 161 - 166
  • [9] Comparative Expedited Regulatory Programs of U.S Food & Drug Administration and Project Orbis Partners
    Hotaki, Lauren T. T.
    Shrestha, Anu
    Bennett, Monica P.
    Valdes, Ivelisse L.
    Lee, Sso H.
    Wang, Yinghua
    Spillman, Dianne
    MacAulay, Tina
    Hunt, Melissa
    Gervais, Julie
    Mafi, Maral
    Panetta, Vincent
    Looi, Yee Hoo
    Shum, Michael
    Atiek, Eiman
    Meincke, Ricarda
    Rohr, Ulrich-Peter
    Ainbinder, Denize
    Boehm-Cagan, Anat
    Luxenburg, Osnat
    Cerqueira, Mateus Rodrigues
    Mouawad, Laila Sofia
    Thees, Maria Fernanda Reis e Silva
    Prasad, Krishna
    de Claro, R. Angelo
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (04) : 875 - 885
  • [10] Comparative Expedited Regulatory Programs of U.S Food & Drug Administration and Project Orbis Partners
    Lauren T. Hotaki
    Anu Shrestha
    Monica P. Bennett
    Ivelisse L. Valdes
    Sso H. Lee
    Yinghua Wang
    Dianne Spillman
    Tina MacAulay
    Melissa Hunt
    Julie Gervais
    Maral Mafi
    Vincent Panetta
    Yee Hoo Looi
    Michael Shum
    Eiman Atiek
    Ricarda Meincke
    Ulrich-Peter Rohr
    Denize Ainbinder
    Anat Boehm-Cagan
    Osnat Luxenburg
    Mateus Rodrigues Cerqueira
    Laila Sofia Mouawad
    Maria Fernanda Reis e Silva Thees
    Krishna Prasad
    R. Angelo de Claro
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 875 - 885
12345